Lilly Pulitzer Is Launching Menswear—and a New Exhibit With Never-Before-Seen Slim Aarons Photos, Too
The new mens range debuted at a VIP fashion show in Palm Beach last week, and will arrive in stores in February for the ...
Novo Nordisk reportedly launches Wegovy in China
Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...
Weight loss drugs are more likely to be covered on government-funded insurance than on private plans
New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...
Becker's Hospital Review1h
Drugmakers' 340B rebate fight, explained
Johnson & Johnson and Eli Lilly both sued the federal government this month over the future of their respective 340B drug rebate plans.
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Eli Lilly follows J&J in suing Biden administration over 340B rebates
Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead ...
Eli Lilly & Co (LLY) Receives a Hold from Evercore ISI
Evercore ISI analyst Umer Raffat maintained a Hold rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last ...
STAT4h
Pharmalittle: We’re reading about RFK Jr. and vaccines, obesity-drug prescribing for kids, and more
Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...
STAT5h
Novartis ramps up in radiopharma, and Eli Lilly adds Zepbound details
In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...
Zacks.com on MSN5h
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...
Reporter.net6h
Indiana Economic Development Corp. won't pay property taxes on 9,000 Boone County acres, but the county may gain in the long-run
The State of Indiana won’t pay property taxes for 9,000 acres it has bought in Boone County because state and non-profit ...
Barclays Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Barclays analyst Carter Gould maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of $975.00.